DANYELZA Naxitamab Gqgk Advanced Patient User Guide
DANYELZA Naxitamab Gqgk Advanced Patient Specifications Product Name: DANYELZA Type: Monoclonal Antibody Indication: Treatment of pediatric and adult patients with relapsed or refractory high-risk neuroblastoma Dosage Form: Injection Strength: 40 mg/10 mL (4 mg/mL) Product Usage Instructions DANYELZA is indicated…